LSE - Delayed Quote USD
TransDigm Group Incorporated (0REK.L)
1,407.52
-1.03
(-0.07%)
At close: April 30 at 7:07:53 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 19 | 18 | 22 | 21 |
| Avg. Estimate | 2.17B | 2.29B | 8.87B | 9.61B |
| Low Estimate | 2.11B | 2.24B | 8.63B | 9.17B |
| High Estimate | 2.23B | 2.34B | 9B | 9.94B |
| Year Ago Sales | 1.92B | 2.05B | 7.94B | 8.87B |
| Sales Growth (year/est) | 12.96% | 11.92% | 11.70% | 8.33% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0REK.L | -- | -- | -- | -- |
| S&P 500 | 9.70% | 3.97% | 8.29% | 13.85% |
Upgrades & Downgrades
| Maintains | Truist Securities: Buy to Buy | 4/17/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/15/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 4/8/2025 |
| Maintains | Susquehanna: Neutral to Neutral | 4/2/2025 |
| Maintains | Wells Fargo: Overweight to Overweight | 3/25/2025 |
| Upgrade | UBS: Neutral to Buy | 2/24/2025 |